FibroGen Inc (NASDAQ:FGEN)

44.35
Delayed Data
As of Jan 17
 -0.24 / -0.54%
Today’s Change
32.33
Today|||52-Week Range
61.23
+3.40%
Year-to-Date
FibroGen Appoints Enrique Conterno as Its New CEO
Jan 06 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close44.59
Today’s open44.96
Day’s range44.30 - 45.21
Volume835,095
Average volume (3 months)743,371
Market cap$3.9B
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)+40.55%
Earnings growth (this year)+77.64%
Earnings growth (next 5 years)--
Revenue growth (last year)+69.46%
P/E ratio92.4
Price/Sales18.27
Price/Book7.44

Competitors

 Today’s
change
Today’s
% change
ADPTAdaptive Biotechnolo...+0.84+3.07%
MEDPMedpace Holdings Inc-0.09-0.10%
EXELExelixis Inc-0.62-3.03%
SYNHSyneos Health Inc+0.13+0.20%
Data as of 4:00pm ET, 01/17/2020

Financials

Next reporting dateFebruary 26, 2020
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$213.0M
Annual profit (last year)-$86.4M
Net profit margin-40.58%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Francisco, California

Forecasts